Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Annovis Bio Inc. ANVS

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Officials to Present Results from Alzheimer’s Study at AAIC 2024

Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), will be presenting results from its latest Alzheimer’s study at the Alzheimer’s Association International Conference(R) 2024 (“AAIC”). The conference … Continue reading

Posted in Annovis Bio Inc. ANVS | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Is ‘One to Watch’

Recent Achievements Investment Considerations Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”). Annovis Bio stands out by developing a drug that targets multiple … Continue reading

Posted in Annovis Bio Inc. ANVS | Leave a comment